PT  - JOURNAL ARTICLE
AU  - Mews, Makaela A.
AU  - Naj, Adam C.
AU  - Griswold, Anthony J.
AU - Alzheimer’s Disease Genetics Consortium
AU  - Below, Jennifer E.
AU  - Bush, William S.
TI  - Brain and Blood Transcriptome-Wide Association Studies Identify Five Novel Genes Associated with Alzheimer’s Disease
AID  - 10.1101/2024.04.17.24305737
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.04.17.24305737
4099  - http://medrxiv.org/content/early/2024/04/19/2024.04.17.24305737.short
4100  - http://medrxiv.org/content/early/2024/04/19/2024.04.17.24305737.full
AB  - INTRODUCTION Transcriptome-wide Association Studies (TWAS) extend genome-wide association studies (GWAS) by integrating genetically-regulated gene expression models. We performed the most powerful AD-TWAS to date, using summary statistics from cis-eQTL meta-analyses and the largest clinically-adjudicated Alzheimer’s Disease (AD) GWAS.METHODS We implemented the OTTERS TWAS pipeline, leveraging cis-eQTL data from cortical brain tissue (MetaBrain; N=2,683) and blood (eQTLGen; N=31,684) to predict gene expression, then applied these models to AD-GWAS data (Cases=21,982; Controls=44,944).RESULTS We identified and validated five novel gene associations in cortical brain tissue (PRKAG1, C3orf62, LYSMD4, ZNF439, SLC11A2) and six genes proximal to known AD-related GWAS loci (Blood: MYBPC3; Brain: MTCH2, CYB561, MADD, PSMA5, ANXA11). Further, using causal eQTL fine-mapping, we generated sparse models that retained the strength of the AD-TWAS association for MTCH2, MADD, ZNF439, CYB561, and MYBPC3.DISCUSSION Our comprehensive AD-TWAS discovered new gene associations and provided insights into the functional relevance of previously associated variants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the National Institute on Aging (NIA) (Grant: RF1AG061351; PIs: Adam C. Naj, PhD, Jennifer E. Below, PhD, and William S. Bush, PhD & Grant: RF1AG070935; PIs: Anthony J. Griswold, PhD and William S. Bush, PhD).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University Hospitals IRB waived ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors